Filing Details
- Accession Number:
- 0001140361-24-009271
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-23 16:37:35
- Reporting Period:
- 2024-02-21
- Accepted Time:
- 2024-02-23 16:37:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9326 | Balchem Corp | BCPC | Chemicals & Allied Products (2800) | 132578432 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378228 | L Theodore Harris | C/O Balchem Corporation 5 Paragon Drive Montvale NJ 07645 | Chairman, President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-02-21 | 10,797 | $152.97 | 85,294 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-21 | 16,015 | $153.75 | 69,279 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-21 | 2,667 | $154.84 | 66,612 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-21 | 200 | $155.91 | 66,412 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-22 | 10,000 | $54.87 | 76,412 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-22 | 24,350 | $60.85 | 100,762 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-22 | 14,497 | $153.56 | 86,265 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-22 | 13,989 | $154.66 | 72,276 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-22 | 5,864 | $155.25 | 66,412 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Acquisiton | 2024-02-22 | 10,000 | $0.00 | 10,000 | $54.87 |
| Common Stock | Stock Options (right to buy) | Acquisiton | 2024-02-22 | 24,350 | $0.00 | 24,350 | $60.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-04-28 | No | 4 | M | Direct | |
| 0 | 2026-02-23 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiples sales ranging from $152.3350 to $153.3200 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- This transaction was executed in multiples sales ranging from $153.3400 to $154.2900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- This transaction was executed in multiples sales ranging from $154.4700 to $155.3800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- Exercise of fully vested non-qualified stock options.
- This transaction was executed in multiple sales ranging from $153.0800 to $154.0775 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- This transaction was executed in multiple sales ranging from $154.0800 to $155.0750 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- This transaction was executed in multiple sales ranging from $155.0800 to $155.5700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- Stock options that vested 20% on April 28, 2016, 40% on April 28, 2017, and 40% on April 28, 2018, and are exercisable.
- Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.
Billionaire Hedge Funds
